News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lee's Pharmaceutical Completes Successful China Test of Anti-Depression Drug



10/2/2013 11:54:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

October 2, 2013 -- Lee's Pharmaceutical Holdings of Hong Kong reported that its China registration study of Trazodone as a treatment for depression met its primary endpoint. Lee’s in-licensed Trazodone (Trittico®) from Italian pharma Angelini. The Trazodone cohort of the trial showed a statistically significant improvement over placebo on a depression measurement scale. More details....

Stock Symbol: (HK: 0950)

Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES